862205-59-2 Usage
Uses
Used in Pharmaceutical Industry:
(2-(aminomethyl)-5-fluorophenyl)methanol is used as a building block and intermediate for the synthesis of various pharmaceutical compounds. Its unique structure, containing a fluorine atom and an amino group, makes it valuable in drug development and medicinal chemistry.
Used in Organic Synthesis:
(2-(aminomethyl)-5-fluorophenyl)methanol may have potential applications in organic synthesis, where its specific functional groups can be utilized to create new compounds or modify existing ones.
Used in Chemical Research:
(2-(aminomethyl)-5-fluorophenyl)methanol may also be used in chemical research to study the effects of fluorination and amination on the properties and reactivity of organic molecules, contributing to the advancement of synthetic chemistry and the development of new pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 862205-59-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,2,2,0 and 5 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 862205-59:
(8*8)+(7*6)+(6*2)+(5*2)+(4*0)+(3*5)+(2*5)+(1*9)=162
162 % 10 = 2
So 862205-59-2 is a valid CAS Registry Number.
862205-59-2Relevant academic research and scientific papers
1,6 - SUBSTITUTED (3R,6R) -3- (2,3-DIHYDRO-1H-INDEN-2-YL)-2,5-PIPERAZINEDIONE DERIVATIVES AS OXYTOCIN RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PRE-TERM LABOUR, DYSMENORRHEA AND ENDOMETRIOSIS
-
Page/Page column 50-51, (2008/06/13)
The present invention relates to compound S of Formula (I).
NEW PYRIDIN-2-ONE COMPOUNDS USEFUL AS INHIBITORS OF THROMBIN
-
Page/Page column 115, (2008/06/13)
There is provided a compound of formula I, wherein the dashed line, R1, R2, R3a, R3b, A, D, E, G and L have meanings given in the description, which compounds are useful as, or are useful as prodrugs of, competitive inhibitors of trypsin-like proteases, such as thrombin, and thus, in particular, in the treatment of conditions where inhibition of thrombin is beneficial (e.g. conditions, such as thrombo-embolisms, where inhibition of thrombin is required or desired, and/or conditions where anticoagulant therapy is indicated).
